Follow
Max Finger Bou
Title
Cited by
Cited by
Year
Characterizing a thermostable Cas9 for bacterial genome editing and silencing
I Mougiakos, P Mohanraju, EF Bosma, V Vrouwe, M Finger-Bou, ...
Nature communications 8 (1), 1-11, 2017
1432017
Replacing the Calvin cycle with the reductive glycine pathway in Cupriavidus necator
NJ Claassens, G Bordanaba-Florit, CAR Cotton, A De Maria, ...
Metabolic Engineering 62, 30-41, 2020
1072020
The ongoing quest to crack the genetic code for protein production
T Nieuwkoop, M Finger-Bou, J van der Oost, NJ Claassens
Molecular cell 80 (2), 193-209, 2020
382020
Bicistronic Design-Based Continuous and High-Level Membrane Protein Production in Escherichia coli
NJ Claassens, M Finger-Bou, B Scholten, F Muis, JJ De Groot, JW de Gier, ...
ACS synthetic biology 8 (7), 1685-1690, 2019
252019
CRISPR with a Happy Ending: Non‐Templated DNA Repair for Prokaryotic Genome Engineering
M Finger‐Bou, E Orsi, J van der Oost, RHJ Staals
Biotechnology Journal, 1900404, 2020
142020
Not So Giant Steps On Tuning Protein Production And Diminished Genomes
M Finger-Bou
Wageningen University, 2023
2023
Towards a formate bio-economy: establishing the reductive glycine pathway
O Yishai, N Claassens, MF Bou, J Verbunt, G Scarinci, A Bar-Even
2018
Towards a sustainable, efficient formate bio-economy: replacing the Calvin cycle by a highly efficient synthetic pathway in a formatotroph
NJ Claassens, G Bordanaba-Florit, M Finger-Bou, CAR Cotton, ...
The system can't perform the operation now. Try again later.
Articles 1–8